Funding Rounds
MISSION Therapeutics

MISSION Therapeutics Series C (2016, $76M)

MISSION Therapeutics

Deubiquitylating enzyme (DUB) drug discovery and development platform.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series C

Raised Amount: $76.30M

Raised Date: 2016-02-01

Investors